Relationships between obesity and the clinical severity of psoriasis in Taiwan

Huang, Yu Huei; Yang, Lichen; Hui, Rc Y.; Chang, Ya‐Ching; Yang, Ya‐Wen; Yang, Chih‐Hsun; Chen, Yun-Hsuan; Chung, Wen-Jung; Kuan, Yue-Zon; Chiu, Cheng-Tang

doi:10.1111/j.1468-3083.2010.03573.x

Cited by 33 publications

(31 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In PsO, disease severity may be associated with increased BMI or obesity 43,56,57,58,59,60 . PsO was also reported to be associated with obesity or BMI > 25 kg/m 2 , regardless of severity 61,62,63 .…”

Section: Methodsmentioning

confidence: 99%

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

Roubille

Richer²,

Starnino³

et al. 2015

J Rheumatol

112

101

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

Roubille

Richer²,

Starnino³

et al. 2015

J Rheumatol

112

101

View full text Add to dashboard Cite

show abstract

“…A case-control study of 560 psoriasis patients found the odds ratio was 1.6 (95% CI, 1.1-2.1) for BMI 26-29 (overweight subjects) and 1.9 (95% CI, 1.2-2.8) for BMI greater than 29, corresponding to obese people [79]. A number of cohort and case-control studies have reported higher BMI in patients with psoriasis compared with the general population [16] and with other patients undergoing coronary angiography [17], while others have found an increased risk of incident psoriasis [18], or of more severe psoriasis in people with a higher BMI [19,20]. Bariatric surgery in obese patients has been shown to significantly improve psoriasis [21,22] and to have an impact on quality of life [22].…”

Section: Obesitymentioning

confidence: 99%

Psoriasis beyond the skin: a review of the literature on cardiometabolic and psychological co-morbidities of psoriasis

Puig¹,

Kirby²,

Mallbris³

et al. 2014

European Journal of Dermatology

View full text Add to dashboard Cite

Psoriasis is increasingly associated with a range of co-morbid diseases and risk factors. Patients with co-morbidities are more likely to need hospitalisation for non-dermatological conditions, and incur greater total costs than those without co-morbidities. A literature review was conducted on two of the most common co-morbidities of psoriasis (cardiovascular (CV) and psychological co-morbidities), to establish their incidence and impact and to raise awareness of unanswered questions and highlight knowledge gaps. A large number of small controlled or cross-sectional studies report increased prevalence of cardiometabolic and psychological co-morbidities in psoriasis patients. A number of large cohort studies documented the incidence of various cardiometabolic comorbidities. Severe psoriasis is associated with increased mortality, and the most common cause of death is CV disease. Studies on the management of co-morbidities and their impact on psoriasis treatment are scarce. Many questions on the co-morbidities of psoriasis remain to be answered.

show abstract

“…Huang ve ark. 18 , 399 hastanın katıldığı çalışmalarında VKİ ile klinik olarak şiddetli psoriasis arasında anlamlı seviyede doğrusal ilişki saptamışlardır. Ancak önceki çalışmanın aksine, kadın hastalarda aşırı kilo ile psoriasis şiddeti arasında ilişki bulamamışlar, erkek hastalarda ise anlamlı oranda ilişki tespit ederek erkeklerde obezitenin psoriasis şiddeti üzerine etkisinin kadınlara göre daha belirgin olduğu sonucuna varmışlardır.…”

Section: Gereç Ve Yöntemunclassified

“…Son yıllarda yapılan çalışmalarda, obezitenin, psoriasis prevalansını arttırdığı veya psoriasisin başlangıcını tetiklediği öne sürülmektedir 11,14,15 . Ayrıca obezite ile psoriasisin klinik şiddeti arasındaki ilişkiyi araştıran çalışmalar da mevcuttur [16][17][18] . Bu çalışmamızda kronik plak psoriasisli hastalarda, önemli bir toplum sorunu olan obezitenin psoriasisin klinik şiddeti üzerine etkisinin araştırılması amaçlanmıştır.…”

Section: Introductionunclassified

Impact of obesity on disease severity in patients with plaque type psoriasis

Korkmaz¹,

Kayiran²,

Özgöztaşı³

2014

TURKDERM

View full text Add to dashboard Cite

Background and Design:Psoriasis is a chronic inflammatory systemic disease involving the skin, scalp, nails, and the joints and is characterized by periods of remission and exacerbation. Although the pathogenesis of psoriasis is not fully understood, many genetic and environmental factors are believed to have a role in the development of the disease. Obesity, smoking, family history of psoriasis, repetitive physical traumas and major stress disorders are the factors thought to affect the severity and progress of the disease. In this study, we aimed to investigate the effects of obesity on the clinical severity of psoriasis in patients with chronic plaque psoriasis. Materials and Methods: Three hundred twenty-five outpatients with chronic plaque-type psoriasis were enrolled in the study. Body Mass Index (BMI) and Psoriasis Area and Severity Index (PASI) values were recorded for each patient. Results: When normal, overweight and obese psoriasis patients were compared, a statistically significant difference was not found in disease severity (p=0.707). There was also no significant correlation between BMI and PASI values (r=0.006, p=0916). Conclusion: Although no effect of obesity on the severity of the disease was shown in our study, further controlled population based studies are needed to investigate the possible role of obesity in triggering and beginning of the disease. (Turkderm 2014; 48: 193-6)

show abstract

Relationships between obesity and the clinical severity of psoriasis in Taiwan

Abstract: In psoriasis patients, obesity is associated with a more severe disease, especially in men. Bodyweight control may be important for the management of psoriasis.

Cited by 33 publications

References 28 publications

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

Psoriasis beyond the skin: a review of the literature on cardiometabolic and psychological co-morbidities of psoriasis

Impact of obesity on disease severity in patients with plaque type psoriasis

Contact Info

Product

Resources

About